A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma

2008 ◽  
Vol 143 (2) ◽  
pp. 201-209 ◽  
Author(s):  
Owen A. O’Connor ◽  
Carol Portlock ◽  
Craig Moskowitz ◽  
David Straus ◽  
Paul Hamlin ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Clinical Experience ◽  
Phase Ii ◽  
Cell Lymphoma ◽  
The Novel ◽  
Multicentre Phase ◽  
Non Hodgkin Lymphoma ◽  
Mantle Cell

scholarly journals A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

2014 ◽  
Vol 165 (6) ◽  
pp. 768-776 ◽  
Author(s):  
Michinori Ogura ◽  
Kiyoshi Ando ◽  
Tatsuya Suzuki ◽  
Kenichi Ishizawa ◽  
Sung Yong Oh ◽  
...  
Keyword(s):  
B Cell ◽  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
Multicentre Phase ◽  
Non Hodgkin Lymphoma ◽  
Mantle Cell

scholarly journals Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

2010 ◽  
Vol 101 (9) ◽  
pp. 2059-2064 ◽  
Author(s):  
Ken Ohmachi ◽  
Kiyoshi Ando ◽  
Michinori Ogura ◽  
Toshiki Uchida ◽  
Kuniaki Itoh ◽  
...  
Keyword(s):  
B Cell ◽  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
Non Hodgkin Lymphoma ◽  
Multicenter Phase ◽  
Mantle Cell

Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14)

2017 ◽  
Vol 59 (7) ◽  
pp. 1606-1613
Author(s):  
Kuniaki Itoh ◽  
Tadahiko Igarashi ◽  
Hiroyuki Irisawa ◽  
Nobuyuki Aotsuka ◽  
Shinichi Masuda ◽  
...  
Keyword(s):  
B Cell ◽  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
Low Grade ◽  
Non Hodgkin Lymphoma ◽  
Randomized Phase Ii ◽  
Mantle Cell

Phase II trial of bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or elderly mantle cell lymphoma in Japan.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e19050-e19050
Author(s):  
Kenichi Ishizawa ◽  
Michinori Ogura ◽  
Dai Maruyama ◽  
Yasunobu Abe ◽  
Kiyoshi Ando ◽  
...  
Keyword(s):  
B Cell ◽  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
Non Hodgkin Lymphoma ◽  
Mantle Cell

scholarly journals Mantle Cell Lymphoma Mimicking Rectal Carcinoma

2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Engin Kelkitli ◽  
Hilmi Atay ◽  
Levent Yıldız ◽  
Ahmet Bektaş ◽  
Mehmet Turgut
Keyword(s):  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Rectal Carcinoma ◽  
Cell Lymphoma ◽  
Treatment Options ◽  
Extranodal Involvement ◽  
Non Hodgkin Lymphoma ◽  
Rectal Involvement ◽  
Mantle Cell ◽  
Rectal Mass

Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma. After the (11;14) translocation was identified as its constant finding in 1992, MCL was recognized as a separate subgroup of non-Hodgkin lymphoma (NHL). In MCL, extranodal involvement may be observed in the bone marrow, the spleen, the liver, and the gastrointestinal system (GIS). Cases of MCL that present with a massive and solitary rectal mass are rare in the literature. In this case report, our aim was to present an MCL patient with a rarely observed solitary rectal involvement mimicking rectal carcinoma and to discuss treatment options for this patient.

scholarly journals An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

2018 ◽  
Vol 184 (2) ◽  
pp. 215-222 ◽  
Author(s):  
David J. Andorsky ◽  
Kathryn S. Kolibaba ◽  
Sarit Assouline ◽  
Andres Forero‐Torres ◽  
Vicky Jones ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Hodgkin Lymphoma ◽  
Cell Lymphoma ◽  
Phase 2 ◽  
Open Label ◽  
Non Hodgkin Lymphoma ◽  
Phase 2 Trial ◽  
Mantle Cell ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document